Adicet Bio, Inc.ACETNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P38
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -14.07% |
| Q3 2025 | 13.71% |
| Q2 2025 | -8.39% |
| Q1 2025 | 2.79% |
| Q4 2024 | 7.27% |
| Q3 2024 | -0.93% |
| Q2 2024 | -6.41% |
| Q1 2024 | 2.20% |
| Q4 2023 | 39.60% |
| Q3 2023 | -49.79% |
| Q2 2023 | -4.71% |
| Q1 2023 | -5.57% |
| Q4 2022 | -37.33% |
| Q3 2022 | -1.22% |
| Q2 2022 | -582.51% |
| Q1 2022 | 130.28% |
| Q4 2021 | -13.36% |
| Q3 2021 | -26.63% |
| Q2 2021 | 49.30% |
| Q1 2021 | -128.41% |
| Q4 2020 | 31.53% |
| Q3 2020 | -58.23% |
| Q2 2020 | -14.20% |
| Q1 2020 | -5.29% |
| Q4 2019 | 52.86% |
| Q3 2019 | -229.83% |
| Q2 2019 | -5.63% |
| Q1 2019 | 95.09% |
| Q4 2018 | -885.03% |
| Q3 2018 | 36.00% |
| Q2 2018 | -38.36% |
| Q1 2018 | 85.03% |
| Q4 2017 | -1627.38% |
| Q3 2017 | -111.38% |
| Q2 2017 | 162.84% |
| Q1 2017 | 847.09% |
| Q4 2016 | -84.11% |
| Q3 2016 | -14.50% |
| Q2 2016 | -37.76% |
| Q1 2016 | 16.90% |